Henan Lingrui Pharmaceutical Co., Ltd. (SHSE: 600285)
Health Care · Pharmaceuticals · CN
CN¥19.66
+3.04% today · -11.5% 1Y
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE: 600285) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.66B and employs 2,789 people.
Over the last twelve months the share price has lost 11.5%, trading between 18.51 and 23.65.
Tweenvest scores Henan Lingrui Pharmaceutical Co., Ltd. across four factors: quality 87/100, value 74/100, growth 57/100, dividend 100/100. Its strongest factor is dividend.
600285 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.66B
- Revenue (TTM)
- $574.46M
- P/E
- 14.30
- EPS
- 1.37
- Dividend yield
- 5.77%
- Beta (5Y)
- -0.02
- 52-week high
- CN¥23.65
- 52-week low
- CN¥18.51
- Avg volume (3M)
- —
- Shares outstanding
- 567.12M
- Employees
- 2,789
- Next earnings
- —
About Henan Lingrui Pharmaceutical Co., Ltd.
Established in 1992 and headquartered in Xinyang, China, Henan Lingrui Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products throughout the Chinese market. The company offers a broad catalog of approximately 100 different medications, provided in ten distinct dosage formats such as adhesive plasters, tablets, capsules, granules, and tinctures. Prominent items in their product line include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules.
- ISIN
- CNE000001501
- Founded
- 1992
- Listed since
- Oct 18, 2000
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alivus Life Sciences LimitedNSEI: ALIVUS | $1.68B | Rs1,326.30 | -3.49% |
| Eris Lifesciences LimitedNSEI: ERIS | $1.68B | Rs1,170.70 | -1.61% |
| Bora Pharmaceuticals Co., Ltd.TWSE: 6472 | $1.68B | NT$421.00 | +0.12% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd.SHSE: 600572 | $1.67B | CN¥4.41 | +2.32% |
| Hanall Biopharma Co., Ltd.KOSE: A009420 | $1.66B | ₩44,000.00 | -4.56% |
| Ocular Therapeutix, Inc.NasdaqGM: OCUL | $1.66B | $7.58 | +0.46% |
| Tibet Cheezheng Tibetan Medicine Co., Ltd.SZSE: 002287 | $1.66B | CN¥19.56 | +0.93% |
| Alembic Pharmaceuticals LimitedNSEI: APLLTD | $1.63B | Rs800.95 | -1.75% |
Figures last refreshed Oct 11, 2026.